AU Stock MarketDetailed Quotes
ACL Australian Clinical Labs Ltd
- 3.500
- +0.030+0.86%
20min DelayMarket Closed Nov 22 16:00 AET
704.82MMarket Cap29.17P/E (Static)
3.530High3.440Low284.11KVolume3.440Open3.470Pre Close997.93KTurnover3.85552wk High0.16%Turnover Ratio201.38MShares2.08152wk Low0.12EPS TTM606.89MFloat Cap5.250Historical High29.17P/E (Static)173.40MShs Float2.081Historical Low0.12EPS LYR2.59%Amplitude0.10Dividend TTM3.97P/B1Lot Size2.86%Div YieldTTM
Australian Clinical Labs Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|
| Total revenue | -0.34%689.73M | -30.04%692.1M | 54.26%989.3M | 641.31M |
| Operating revenue | -0.34%689.73M | -30.04%692.1M | 54.26%989.3M | --641.31M |
| Cost of revenue | -5.36%119.32M | -39.26%126.08M | 73.59%207.59M | 119.59M |
| Gross profit | 0.78%570.41M | -27.59%566.02M | 49.83%781.71M | 521.73M |
| Operating expense | 0.09%514.5M | 0.00%514.05M | 23.41%514.03M | 416.54M |
| Selling and administrative expenses | 5.14%312.67M | -5.29%297.39M | 25.76%314M | --249.69M |
| -General and administrative expense | 5.14%312.67M | -5.29%297.39M | 25.76%314M | --249.69M |
| Depreciation amortization depletion | 4.62%128.43M | 15.70%122.76M | 20.49%106.1M | --88.05M |
| -Depreciation and amortization | 4.62%128.43M | 15.70%122.76M | 20.49%106.1M | --88.05M |
| Other operating expenses | -21.83%73.4M | -0.03%93.9M | 19.20%93.93M | --78.8M |
| Operating profit | 7.59%55.91M | -80.59%51.97M | 154.47%267.68M | 105.19M |
| Net non-operating interest income (expenses) | -20.87%-16.54M | -16.91%-13.68M | 46.54%-11.7M | -21.89M |
| Non-operating interest income | 175.27%501K | 304.44%182K | -40.00%45K | --75K |
| Non-operating interest expense | 37.20%4.86M | 164.38%3.54M | -87.76%1.34M | --10.94M |
| Total other finance cost | 18.00%12.18M | -0.82%10.33M | -5.62%10.41M | --11.03M |
| Other net income (expenses) | -129.99%-3.01M | 1,034.39%10.03M | -131.96%-1.07M | 3.36M |
| Other non-operating income (expenses) | -129.99%-3.01M | 1,034.39%10.03M | -131.96%-1.07M | --3.36M |
| Income before tax | -24.72%36.37M | -81.05%48.31M | 194.16%254.9M | 86.65M |
| Income tax | -1.19%12.12M | -83.96%12.27M | 191.27%76.5M | 26.26M |
| Earnings from equity interest net of tax | ||||
| Net income | -32.73%24.24M | -79.80%36.04M | 195.42%178.4M | 60.39M |
| Net income continuous operations | -32.73%24.24M | -79.80%36.04M | 195.42%178.4M | --60.39M |
| Noncontrolling interests | 119.86%310K | -10.76%141K | 887.50%158K | 16K |
| Net income attributable to the company | -33.33%23.93M | -79.86%35.9M | 195.24%178.24M | 60.37M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | -33.33%23.93M | -79.86%35.9M | 195.24%178.24M | 60.37M |
| Diluted earnings per share | -32.79%0.1203 | -79.79%0.179 | 123.10%0.8855 | 0.3969 |
| Basic earnings per share | -32.77%0.12 | -79.82%0.1785 | 122.88%0.8846 | 0.3969 |
| Dividend per share | -79.17%0.1 | 300.00%0.48 | 0.12 | |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data